Home2018-10-17T13:47:37+00:00
What we do—

Changing the world

UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Read More
Latest news—

UCLB spinout Endomag wins the prestigious British Business Innovation Award from the Institute of Physics

Endomag, the surgical guidance company, has won a prestigious British Business Innovation Award from the Institute of Physics (IOP), presented at the Houses of Parliament in London.

Read More
Featured Technology—

Novel method of analysis of stroke data

Stroke is the leading cause of adult disability in the UK at an estimated cost of £7 billion a year. UCL has developed a system for predicting clinical outcomes so as to provide advance information on the optimum clinical management of each patient.
Read more
Spotlight—

Children are not small adults.

When it comes to the use of medicines, children cannot be treated as small adults.  Find out how our spinout, Therakind, is ensuring that children’s medicine used today is both safe and effective.

Read More
Featured Technology—

SnakeGrid

SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.

Read more

Latest news and highlights

Read More News

UCLB spinout Endomag wins the prestigious British Business Innovation Award from the Institute of Physics

/ UCLB News
UCLB spinout Endomag, the surgical guidance company, has won a prestigious British Business Innovation Award from the Institute of Physics ...

Global University Venturing Interviews UCLTF’s David Grimm

/ Spinout News, UCLB News
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the ...

Announcing Cengiz Tarhan’s retirement from UCLB

/ Anne Lane, Cengiz Tarhan, UCLB News
Having spent 30 years at UCL, 25 of those at UCLB, Cengiz Tarhan announces his intention to retire, stepping down ...

UCLB Spinout Orchard Therapeutics Proposes to Raise up to $172.5 million in an IPO

/ Spinout News
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative ...

FIND THE RIGHT MATCH

Whether you’re an academic or looking for technologies, find your UCLB contact here.

 

Bringing innovation to life

0
Active spinouts
0
Active licences in 2017
0
Drug discoveries
0
New patent applications